|
[1] FINDLAY AR, GOYAL NA, MOZAFFAR T. An overview of polymyositis and dermatomyositis[J]. Muscle Nerve, 2015, 51 (5) :638-656.
|
|
[2] van de VLEKKERT J, HOOGENDIJK JE, de VISSER M. Myositis with endomysial cell invasion indicates inclusion body myositis even if other criteria are not fulfilled[J]. Neuromuscul Disord, 2015, 25 (6) :451-456.
|
|
[3] MILISENDA JC, SELVA-O’CALLAGHAN A, GRAU JM. The diagnosis and classification of polymyositis[J]. J Autoimmun, 2014, 48-49:118-121.
|
|
[4] BOHLMEYER TJ, WU AH, PERRYMAN MB. Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis[J]. Rheum Dis Clin North Am, 1994, 20 (4) :845-856.
|
|
[5] MATHUR T, MANADAN AM, THIAGARAJAN S, et al. Serum transaminases are frequently elevated at time of diagnosis of idiopathic inflammatory myopathy and normalize with creatine kinase[J]. J Clin Rheumatol, 2014, 20 (3) :130-132.
|
|
[6] JEPSEN P, GRNBK L, VILSTRUP H. Worldwide incidence of autoimmune liver disease[J]. Dig Dis, 2015, 33 (Suppl 2) :2-12.
|
|
[7] HENEGHAN MA, YEOMAN AD, VERMA S, et al. Autoimmune hepatitis[J]. Lancet, 2013, 382 (9902) :1433-1444.
|
|
[8] WANG TT, LU CL, FAN XL, et al. Clinical and pathological features of autoimmune hepatitis-primary biliary cholangitis overlap syndrome versus autoimmune hepatitis[J]. J Clin Hepatol, 2017, 33 (11) :2179-2185. (in Chinese) 王婷婷, 鲁昌立, 凡小丽, 等.自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征的临床及病理学特征分析[J].临床肝胆病杂志, 2017, 33 (11) :2179-2185.
|
|
[9] OHIRA H, ABE K, TAKAHASHI A. Involvement of the liver in rheumatic diseases[J]. Clin J Gastroenterol, 2012, 5 (1) :9-14.
|
|
[10] ZIERDEN M, KHNEN E, ODENTHAL M, et al. Effects and regulation of autoreactive CD8+T cells in a transgenic mouse model of autoimmune hepatitis[J]. Gastroenterology, 2010, 139 (3) :975-986.
|
|
[11] MATSUMOTO T, KOBAYASHI S, SHIMIZU H, et al. The liver in collagen diseases:Pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver[J]. Liver, 2000, 20 (5) :366-373.
|
|
[12] TJRNLUND A, TANG Q, WICK C, et al. Abatacept in the treatment of adult dermatomyositis and polymyositis:A randomised, phase IIb treatment delayed-start trial[J]. Ann Rheum Dis, 2018, 77 (1) :55-62.
|
|
[13] TERZIROLI BERETTA-PICCOLI B, MIELI-VERGANI G, VERGANI D. Autoimmune hepatitis:Standard treatment and systematic review of alternative treatments[J]. World J Gastroenterol, 2017, 23 (33) :6030-6048.
|
|
[14] FLORES A, MAYO MJ. Primary biliary cirrhosis in 2014[J].Curr Opin Gastroenterol, 2014, 30 (3) :245-252.
|
|
[15] LI QQ, ZHOU XM, QI XS, et al. Recommendations for The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) [J]. J Clin Hepatol, 2018, 34 (6) :1191-1192. (in Chinese) 李谦谦, 周新苗, 祁兴顺, 等.《2018年英国胃肠病学会/英国PBC协作组原发性胆汁性胆管炎治疗及管理指南》推荐意见[J].临床肝胆病杂志, 2018, 34 (6) :1191-1192.
|
DownLoad: